- Research works
- 108 ◆ 0% vs 2013–17
- Citations
- 2.7k 25.4 per fractional work
- Top-10% rate
- 10.4% record average 16.5%
- Open access
- 45% world 28%
Not ranked overall: Boehringer Ingelheim (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 8.7×. Every wedge is a field page.
- Veterinary 8.7×
- Immunology and Microbiology 7.3×
- Pharmacology, Toxicology and Pharmaceutics 3.5×
- Medicine 3.0×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Agricultural and Biological Sciences 1.9×
- Mathematics 1.1×
- Decision Sciences 0.7×
- Chemistry 0.3×
- Health Professions 0.3×
- Arts and Humanities 0.3×
- Business, Management and Accounting 0.2×
- Economics, Econometrics and Finance 0.2×
- Neuroscience 0.1×
- Engineering 0.1×
- Social Sciences 0.1×
- Physics and Astronomy 0.1×
- Computer Science 0.1×
- Psychology 0.0×
Who are the top researchers at Boehringer Ingelheim (Spain)?
Ranked on the composite score, Manuel Cerviño López lead among researchers whose main affiliation is Boehringer Ingelheim (Spain).
- 1 Manuel Cerviño López Spain · #1,589,798 worldwide 0 citations · 19 works
Which keywords describe research at Boehringer Ingelheim (Spain)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Heart Failure, Glycosylation, Clinical Guidelines, Glycemic Control, Insulin Therapy and Antibody Engineering.
- Vaccine
- Immunogenicity
- Biopharmaceuticals
- TGF-ß
- Foot-and-Mouth Disease
- African Swine Fever
- Cardiovascular Outcomes
- Insulin Therapy
- Fc Receptors
- Antibody Engineering
- Heart Failure
- Epidemiology
- Monoclonal Antibodies
- Therapeutic Antibodies
- Glycosylation
- Clinical Guidelines
- Glycemic Control
- Genetic Characterization
- Type 2 Diabetes
- Fibrosis
- Pathogenesis
- Vaccine Development
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Monoclonal Antibodies3▲ 145×3 topics
- Epidemiology3▲ 3.1×13 topics
- Therapeutic Antibodies2▲ 159×2 topics
- Heart Failure2▲ 25×7 topics
- Glycosylation2▲ 93×3 topics
- Antibody Engineering2▲ 147×1 topic
- Clinical Guidelines2▲ 29×3 topics
- Fc Receptors2▲ 147×1 topic
- Glycemic Control2▲ 54×3 topics
- Insulin Therapy2▲ 68×3 topics
- Genetic Characterization2▲ 163×2 topics
- Cardiovascular Outcomes2▲ 137×1 topic
- Type 2 Diabetes2▲ 33×1 topic
- African Swine Fever1▲ 189×1 topic
- Fibrosis1▲ 30×3 topics
- Foot-and-Mouth Disease1▲ 189×1 topic
- Pathogenesis1▲ 11×4 topics
- TGF-ß1▲ 34×2 topics
- Vaccine Development1▲ 21×3 topics
- Biopharmaceuticals1▲ 96×2 topics
- Idiopathic Pulmonary Fibrosis1▲ 108×1 topic
- Immunogenicity1▲ 115×2 topics
- Interstitial Lung Disease1▲ 79×1 topic
- Vaccine1▲ 11×3 topics
Which research topics does Boehringer Ingelheim (Spain) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Diabetes Treatment and Management, Animal Disease Management and Epidemiology and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
- 3 Animal Disease Management and Epidemiology Agronomy and Crop Science 1 works
- 4 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
- 5 Microbial infections and disease research Microbiology 1 works
- 6 HER2/EGFR in Cancer Research Oncology 1 works
- 7 Protein purification and stability Molecular Biology 1 works
- 8 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
- 9 Vector-Borne Animal Diseases Ecology, Evolution, Behavior and Systematics 0 works
- 10 Biosimilars and Bioanalytical Methods Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (Spain)'s research output changed?
Output in 2018–2022 was 0% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sant Cugat
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.